Impact of age and gender on glioblastoma onset, progression, and management
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and fa...
Saved in:
Published in | Mechanisms of ageing and development Vol. 211; p. 111801 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
01.04.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0047-6374 1872-6216 1872-6216 |
DOI | 10.1016/j.mad.2023.111801 |
Cover
Abstract | Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.
•Glioblastoma is the most common primary malignant brain tumor in adults.•The incidence of glioblastoma is higher in males than in females•Chemotherapy is more effective in adult compared to pediatric patients |
---|---|
AbstractList | Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value. Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value. Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age- and gender- dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alterations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value. •Glioblastoma is the most common primary malignant brain tumor in adults.•The incidence of glioblastoma is higher in males than in females•Chemotherapy is more effective in adult compared to pediatric patients |
ArticleNumber | 111801 |
Author | Fuda, Serena Onorato, Angelo Santi, Samuele Salvati, Maurizio Dolci, Susanna Guida, Eugenia Balistreri, Carmela Rita Colopi, Ambra Cesarini, Valeriana |
Author_xml | – sequence: 1 givenname: Ambra surname: Colopi fullname: Colopi, Ambra organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy – sequence: 2 givenname: Serena surname: Fuda fullname: Fuda, Serena organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy – sequence: 3 givenname: Samuele surname: Santi fullname: Santi, Samuele organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy – sequence: 4 givenname: Angelo surname: Onorato fullname: Onorato, Angelo organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy – sequence: 5 givenname: Valeriana surname: Cesarini fullname: Cesarini, Valeriana organization: Department of Biomedicine, Institute of Translational Pharmacology-CNR, Rome, Italy – sequence: 6 givenname: Maurizio surname: Salvati fullname: Salvati, Maurizio organization: Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy – sequence: 7 givenname: Carmela Rita surname: Balistreri fullname: Balistreri, Carmela Rita organization: Cellular and Molecular Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Corso Tukory 211, 90134 Palermo, Italy – sequence: 8 givenname: Susanna orcidid: 0000-0002-6864-3673 surname: Dolci fullname: Dolci, Susanna email: dolci@uniroma2.it organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy – sequence: 9 givenname: Eugenia orcidid: 0000-0002-1690-3277 surname: Guida fullname: Guida, Eugenia email: eugenia.guida@uniroma2.it organization: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36996926$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kLtOwzAUQC0EgvL4ABaUkaEpfiS2IyZU8ahAYoHZunFuK1eJXWwXib8nUFgYmKwrnXN1fY7Jvg8eCTlndMYok1fr2QDdjFMuZowxTdkemTCteCk5k_tkQmmlSilUdUSOU1pTSlnF5SE5ErJpZMPlhDwuhg3YXIRlASsswHfFCn2HsQi-WPUutD2kHAYY54R5WmxiWEVMyQU__cYH8KM5oM-n5GAJfcKzn_eEvN7dvswfyqfn-8X85qm0oha51FyDrljdYm1VZREptBKqmlbUgtbIucJONLatNVjGmRXCtlYJrKGiQJU4IZe7veMtb1tM2QwuWex78Bi2yXDViEY37Bu9-EG37YCd2UQ3QPwwvwFGQO0AG0NKEZfGugx5_F2O4HrDqPlKbdZmTG2-Uptd6tFkf8zf5f851zsHxzzvDqNJ1qG32LmINpsuuH_sTyaYlPg |
CitedBy_id | crossref_primary_10_1016_j_lfs_2024_123018 crossref_primary_10_1002_cnr2_70050 crossref_primary_10_1097_JS9_0000000000001224 crossref_primary_10_1016_j_ijbiomac_2024_137184 crossref_primary_10_1016_j_mad_2024_111952 crossref_primary_10_3389_fnut_2024_1489812 crossref_primary_10_3390_ph18030431 crossref_primary_10_3390_pharmaceutics16111389 crossref_primary_10_5114_pjr_192044 crossref_primary_10_3390_biomedicines12081822 crossref_primary_10_1016_j_heliyon_2024_e27189 crossref_primary_10_3390_nu16111792 crossref_primary_10_1016_j_ijscr_2025_111094 crossref_primary_10_1016_j_mad_2023_111850 crossref_primary_10_3389_fonc_2023_1306164 crossref_primary_10_26683_2786_4855_2024_3_49__59_71 crossref_primary_10_1080_26941899_2024_2415690 crossref_primary_10_1186_s43094_024_00608_2 crossref_primary_10_1097_OR9_0000000000000134 crossref_primary_10_3389_fonc_2024_1435605 crossref_primary_10_3390_cancers16081557 crossref_primary_10_1186_s12964_024_01819_z crossref_primary_10_1016_j_bioactmat_2023_11_007 crossref_primary_10_7759_cureus_73797 crossref_primary_10_4103_crst_crst_250_23 crossref_primary_10_1093_jnen_nlae091 crossref_primary_10_7759_cureus_61165 crossref_primary_10_1016_j_bbih_2024_100859 crossref_primary_10_3390_ijms25137038 |
Cites_doi | 10.1038/nature10833 10.1186/s13046-022-02251-2 10.1038/s41598-018-24580-z 10.2176/nmc.oa.2017-0167 10.1007/s00401-016-1545-1 10.1136/bmj.n1560 10.2217/cns-2017-0026 10.1093/neuonc/noz150 10.1210/endocr/bqab192 10.1056/NEJMoa043330 10.1136/bmjopen-2019-029686 10.1111/j.1750-3639.1993.tb00752.x 10.1158/1078-0432.CCR-19-3874 10.1007/s00401-012-0998-0 10.1016/j.cell.2013.09.034 10.1371/journal.pone.0055597 10.1016/j.prro.2014.03.012 10.1186/s13014-021-01962-8 10.1007/s11060-018-2957-7 10.3171/jns.1999.91.2.0251 10.1002/ijc.27972 10.2174/1874467211205010102 10.1200/JCO.1995.13.1.112 10.1016/j.wneu.2018.01.055 10.3389/fonc.2021.699594 10.1016/j.ijrobp.2009.04.054 10.1093/neuros/nyx349 10.3390/cancers13184731 10.1007/s10014-020-00363-1 10.1002/ijc.31759 10.1007/s00381-015-2945-6 10.2176/nmc.ra.2017-0003 10.1111/febs.15739 10.1093/neuonc/noq191 10.3171/jns.1978.49.3.0333 10.1007/s11060-016-2190-1 10.1093/neuonc/now207 10.1016/j.nicl.2016.03.007 10.1016/j.ccr.2010.03.017 10.3389/fphar.2020.00040 10.3322/caac.21492 10.1016/j.critrevonc.2008.02.005 10.1159/000170088 10.1038/sj.bjc.6602407 10.1093/neuonc/noaa295 10.1172/JCI71048 10.1038/s41598-021-98913-w 10.3389/fphar.2019.00200 10.1126/scitranslmed.aao5253 10.1007/s11547-021-01381-5 10.1002/cncr.32797 10.1038/s41467-022-34959-2 10.2174/156800912799277557 10.1002/ijc.30597 10.1093/neuonc/noy002 10.1007/s00381-012-1890-x 10.1016/j.clineuro.2018.12.021 10.1007/s11060-019-03335-4 10.1038/s41591-018-0337-7 10.1371/journal.pone.0142612 10.3171/2014.2.PEDS13352 10.1101/gad.1596707 10.2165/11594010-000000000-00000 10.3322/caac.21613 10.1158/1535-7163.MCT-12-1162 10.1007/s00381-015-3006-x 10.1002/cncr.24730 10.1093/neuonc/noac079.301 10.1016/j.ccell.2017.08.017 10.1002/ijc.11213 10.1111/bpa.12336 10.3171/jns.1998.89.1.0052 10.1038/sigtrans.2017.40 10.1038/nm.2963 10.1007/978-3-319-91442-8_3 10.1158/1078-0432.CCR-12-3002 10.1126/scisignal.2004088 10.1016/S1470-2045(18)30675-2 10.1186/s40478-018-0513-5 10.1016/j.cytogfr.2015.12.007 10.1016/j.ijrobp.2008.05.034 10.1182/blood-2008-10-184184 10.1007/s00401-015-1405-4 10.1093/aje/kwh154 10.1002/ijc.25864 10.1007/s00701-021-04802-6 10.1001/jamaoncol.2020.1024 10.4049/jimmunol.178.10.6465 10.1016/j.eplepsyres.2016.12.013 10.1016/j.ejca.2014.12.014 10.1016/j.jpeds.2011.12.006 10.1093/neuonc/noab106 10.1002/cncr.21539 10.1200/JCO.2017.76.0611 10.1007/s11060-019-03134-x 10.1007/s11060-018-03015-9 10.1186/s12943-022-01513-z 10.1007/s10552-009-9311-5 10.1007/s10552-013-0330-x 10.1016/j.canep.2021.101948 10.2741/4573 10.1002/pbc.28283 10.1093/neuonc/noz123 10.1093/jnci/djs315 10.1186/s13014-020-01584-6 10.1158/1055-9965.EPI-14-0275 |
ContentType | Journal Article |
Copyright | 2023 Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.mad.2023.111801 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Zoology |
EISSN | 1872-6216 |
ExternalDocumentID | 36996926 10_1016_j_mad_2023_111801 S0047637423000271 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29M 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXLA AAXUO AAYJJ ABCQJ ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACNCT ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGWIK AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HMQ HVGLF HZ~ IHE J1W KOM LX3 M2V M41 MO0 MOBAO MS~ MVM N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SCC SDF SDG SDP SES SEW SNS SPCBC SSN SSU SSZ T5K WUQ X7M YYP ZGI ZXP ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c353t-828a8415be5c74cee0ab6a45040ca88e227ed39cb58ac121c33cbc73e5a40a073 |
IEDL.DBID | AIKHN |
ISSN | 0047-6374 1872-6216 |
IngestDate | Fri Sep 05 02:55:28 EDT 2025 Wed Feb 19 02:23:41 EST 2025 Tue Jul 01 04:17:46 EDT 2025 Thu Apr 24 22:57:33 EDT 2025 Fri Feb 23 02:34:48 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Gender Age Glioblastoma High grade glioma |
Language | English |
License | Copyright © 2023 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c353t-828a8415be5c74cee0ab6a45040ca88e227ed39cb58ac121c33cbc73e5a40a073 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0002-6864-3673 0000-0002-1690-3277 |
PMID | 36996926 |
PQID | 2793989107 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2793989107 pubmed_primary_36996926 crossref_citationtrail_10_1016_j_mad_2023_111801 crossref_primary_10_1016_j_mad_2023_111801 elsevier_sciencedirect_doi_10_1016_j_mad_2023_111801 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2023 2023-04-00 20230401 |
PublicationDateYYYYMMDD | 2023-04-01 |
PublicationDate_xml | – month: 04 year: 2023 text: April 2023 |
PublicationDecade | 2020 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Mechanisms of ageing and development |
PublicationTitleAlternate | Mech Ageing Dev |
PublicationYear | 2023 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Broestl, Rubin (bib14) 2021; 162 Cordier, Monfort, Filippini, Preston-Martin, Lubin, Mueller, Holly, Peris-Bonet, McCredie, Choi, Little, Arslan (bib21) 2004; 159 Lombardi, De Salvo, Brandes, Eoli, Ruda, Faedi, Lolli, Pace, Daniele, Pasqualetti, Rizzato, Bellu, Pambuku, Farina, Magni, Indraccolo, Gardiman, Soffietti, Zagonel (bib58) 2019; 20 Ostrom, Gittleman, Xu, Kromer, Wolinsky, Kruchko, Barnholtz-Sloan (bib73) 2016; 18 Fyllingen, Bo, Reinertsen, Jakola, Sagberg, Berntsen, Salvesen, Solheim (bib36) 2021; 163 Abou-Elkacem, Arns, Brix, Gremse, Zopf, Kiessling, Lederle (bib1) 2013; 12 Malbec, Roget, Schiffer, Iannascoli, Dumas, Arock, Daeron (bib64) 2007; 178 M, Snijders, de Graeff, Teunissen, de Vos (bib62) 2018; 140 Toledo, Sarria-Estrada, Quintana, Maldonado, Martinez-Ricarte, Rodon, Auger, Aizpurua, Salas-Puig, Santamarina, Martinez-Saez (bib102) 2017; 130 Hanif, Muzaffar, Perveen, Malhi, Simjee Sh (bib40) 2017; 18 Schwartzbaum, Ding, Johannesen, Osnes, Karavodin, Ahlbom, Feychting, Grimsrud (bib91) 2012; 104 Li, McLaughlin, Infante-Rivard (bib57) 2009; 20 Brennan, Verhaak, McKenna, Campos, Noushmehr, Salama, Zheng, Chakravarty, Sanborn, Berman, Beroukhim, Bernard, Wu, Genovese, Shmulevich, Barnholtz-Sloan, Zou, Vegesna, Shukla, Ciriello, Yung, Zhang, Sougnez, Mikkelsen, Aldape, Bigner, Van Meir, Prados, Sloan, Black, Eschbacher, Finocchiaro, Friedman, Andrews, Guha, Iacocca, O'Neill, Foltz, Myers, Weisenberger, Penny, Kucherlapati, Perou, Hayes, Gibbs, Marra, Mills, Lander, Spellman, Wilson, Sander, Weinstein, Meyerson, Gabriel, Laird, Haussler, Getz, Chin (bib12) 2013; 155 Korshunov, Ryzhova, Hovestadt, Bender, Sturm, Capper, Meyer, Schrimpf, Kool, Northcott, Zheludkova, Milde, Witt, Kulozik, Reifenberger, Jabado, Perry, Lichter, von Deimling, Pfister, Jones (bib51) 2015; 129 Louis, Perry, Reifenberger, von Deimling, Figarella-Branger, Cavenee, Ohgaki, Wiestler, Kleihues, Ellison (bib60) 2016; 131 Daudigeos-Dubus, Le Dret, Lanvers-Kaminsky, Bawa, Opolon, Vievard, Villa, Pages, Bosq, Vassal, Zopf, Geoerger (bib25) 2015; 10 Thakkar, Dolecek, Horbinski, Ostrom, Lightner, Barnholtz-Sloan, Villano (bib101) 2014; 23 Li, Sun, He, Yin, Du, Zhang (bib56) 2018; 112 Fukai, Arita, Umehara, Yoshioka, Shofuda, Kanematsu, Kodama, Mano, Kinoshita, Okita, Nonaka, Uda, Tsuyuguchi, Sakamoto, Uematsu, Nakao, Mori, Kanemura (bib34) 2020; 37 Chatwin, Cruz Cruz, Green (bib17) 2021; 288 Jiang, Fang, Bao, Zhou, Shen, Ding, Chen, Hu, Lu (bib43) 2013; 8 Ozawa, Brennan, Zienius, Kurian, Hollingworth, Weller, Grant, Hamilton, Ben-Shlomo (bib80) 2019; 9 Adams, Adams, Jackson, Rincon-Torroella, Jallo, Quinones-Hinojosa (bib2) 2016; 32 Vanan, Eisenstat (bib105) 2014; 1 Mackay, Burford, Carvalho, Izquierdo, Fazal-Salom, Taylor, Bjerke, Clarke, Vinci, Nandhabalan, Temelso, Popov, Molinari, Raman, Waanders, Han, Gupta, Marshall, Zacharoulis, Vaidya, Mandeville, Bridges, Martin, Al-Sarraj, Chandler, Ng, Li, Mu, Trabelsi, Brahim, Kisljakov, Konovalov, Moore, Carcaboso, Sunol, de Torres, Cruz, Mora, Shats, Stavale, Bidinotto, Reis, Entz-Werle, Farrell, Cryan, Crimmins, Caird, Pears, Monje, Debily, Castel, Grill, Hawkins, Nikbakht, Jabado, Baker, Pfister, Jones, Fouladi, von Bueren, Baudis, Resnick, Jones (bib63) 2017; 32 Taylor, Furnari, Cavenee (bib100) 2012; 12 Ladomersky, Scholtens, Kocherginsky, Hibler, Bartom, Otto-Meyer, Zhai, Lauing, Choi, Sosman, Wu, Zhang, Lukas, Wainwright (bib52) 2019; 10 Brodbelt, Greenberg, Winters, Williams, Vernon, Collins (bib13) 2015; 51 Patil, Kelly, Yeboa, Buerki, Cioffi, Balaji, Ostrom, Kruchko, Barnholtz-Sloan (bib82) 2021; 23 Chieffo, Tamburrini, Caldarelli, Di Rocco (bib18) 2014; 13 Lehrer, Rheinstein, Rosenzweig (bib54) 2019; 177 Schreck, Ranjan, Skorupan, Bettegowda, Eberhart, Ames, Holdhoff (bib90) 2019; 143 Gao, Aksoy, Dogrusoz, Dresdner, Gross, Sumer, Sun, Jacobsen, Sinha, Larsson, Cerami, Sander, Schultz (bib37) 2013; 6 D'Alessio, Proietti, Sica, Scicchitano (bib22) 2019; 11 Ostrom, Cioffi, Gittleman, Patil, Waite, Kruchko, Barnholtz-Sloan (bib77) 2019; 21 Baumann, Tichy, Schaefer, Steinbach, Mittelbronn, Wagner, Foerch (bib6) 2020; 146 Ettrich, Seufferlein (bib30) 2018; 211 Khuong-Quang, Buczkowicz, Rakopoulos, Liu, Fontebasso, Bouffet, Bartels, Albrecht, Schwartzentruber, Letourneau, Bourgey, Bourque, Montpetit, Bourret, Lepage, Fleming, Lichter, Kool, von Deimling, Sturm, Korshunov, Faury, Jones, Majewski, Pfister, Jabado, Hawkins (bib47) 2012; 124 Khan, Prajapati, Lakhina, Sharma, Prajapati, Chosdol, Sinha (bib46) 2021; 11 Noushmehr, H., D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape and N. Cancer Genome Atlas Research (2010). "Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma." Cancer Cell Alhalaseh, Abdulelah, Abu-Shanab, Armouti, Amarin, Mansour, Sultan, Al-Hussaini (bib3) 2021; 73 Das, Mehrotra, Nair, Kumar, Srivastava, Sahu, Kumar (bib23) 2012; 28 Mizumoto, Tsuboi, Igaki, Yamamoto, Takano, Oshiro, Hayashi, Hashii, Kanemoto, Nakayama, Sugahara, Sakurai, Matsumura, Tokuuye (bib67) 2010; 77 Yang, Wu, Zhang, Zhang, Wu, Wang, Dai, Zhang, Zhang, Peng, Ye, Zeng, Liu, Cheng (bib112) 2022; 21 Zawlik, Vaccarella, Kita, Mittelbronn, Franceschi, Ohgaki (bib116) 2009; 32 Kleihues, Burger, Scheithauer (bib49) 1993; 3 Huang, Li, Li, Zhang, Zong, Zhang (bib41) 2020; 11 Pacifici, Shore (bib81) 2016; 27 Mizumoto, Oshiro, Yamamoto, Kohzuki, Sakurai (bib69) 2017; 57 Tamimi, Juweid (bib98) 2017 Cohen, Pollack, Zhou, Buxton, Holmes, Burger, Brat, Rosenblum, Hamilton, Lavey, Heideman (bib20) 2011; 13 Solomon, Wood, Tihan, Bollen, Gupta, Phillips, Perry (bib94) 2016; 26 Stupp, Mason, van den Bent, Weller, Fisher, Taphoorn, Belanger, Brandes, Marosi, Bogdahn, Curschmann, Janzer, Ludwin, Gorlia, Allgeier, Lacombe, Cairncross, Eisenhauer, Mirimanoff (bib95) 2005; 352 Bains, Antia, Callard, Yates (bib5) 2009; 113 Santosh, Rao (bib87) 2022; 65 Wolff, Driever, Erdlenbruch, Kortmann, Rutkowski, Pietsch, Parker, Metz, Gnekow, Kramm (bib110) 2010; 116 Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib11) 2018; 68 Dobran, Nasi, Chiriatti, Gladi, Somma, Iacoangeli, Scerrati (bib27) 2018; 58 Grill, Massimino, Bouffet, Azizi, McCowage, Canete, Saran, Le Deley, Varlet, Morgan, Jaspan, Jones, Giangaspero, Smith, Garcia, Elze, Rousseau, Abrey, Hargrave, Vassal (bib39) 2018; 36 Ostrom, Adel Fahmideh, Cote, Muskens, Schraw, Scheurer, Bondy (bib78) 2019; 21 Finlay, Boyett, Yates, Wisoff, Milstein, Geyer, Bertolone, McGuire, Cherlow, Tefft (bib31) 1995; 13 Konig, Jakel, von Knebel Doeberitz, Kieser, Eberle, Munter, Debus, Herfarth (bib50) 2021; 16 Ohgaki, Kleihues (bib72) 2013; 19 Cameron, Whiteside, Perry (bib15) 2011; 71 Ladomersky, Zhai, Lauing, Bell, Xu, Kocherginsky, Zhang, Wu, Podojil, Platanias, Mochizuki, Prins, Kumthekar, Raizer, Dixit, Lukas, Horbinski, Wei, Zhou, Pawelec, Campisi, Grohmann, Prendergast, Munn, Wainwright (bib53) 2020; 26 Sim, Morgan, Mason (bib93) 2018; 7 Press, Shafer, Jiang, Buchwald, Abugideiri, Tian, Morgan, Behera, Sengupta, Voloschin, Olson, Hasan, Blumenthal, Curran, Eaton, Shu, Zhong (bib85) 2020; 126 Yang, Warrington, Taylor, Whitmire, Carrasco, Singleton, Wu, Lathia, Berens, Kim, Barnholtz-Sloan, Swanson, Luo, Rubin (bib113) 2019; 11 Furnari, Fenton, Bachoo, Mukasa, Stommel, Stegh, Hahn, Ligon, Louis, Brennan, Chin, DePinho, Cavenee (bib35) 2007; 21 Malmer, Henriksson, Gronberg (bib65) 2003; 106 Schaefer, Kim, Albers, Hoermann, Myers, Whiteside (bib89) 2005; 92 Brandes, Tosoni, Franceschi, Reni, Gatta, Vecht (bib10) 2008; 67 Iacob, Dinca (bib42) 2009; 2 Ostrom, Rubin, Lathia, Berens, Barnholtz-Sloan (bib75) 2018; 20 Bailey, Rios, Lacour, Guerrini-Rousseau, Bertozzi, Leblond, Faure-Conter, Pellier, Freycon, Michon, Puget, Ducassou, Orsi, Clavel (bib4) 2017; 140 Esquenazi, Moussazadeh, Link, Hovinga, Reiner, DiStefano, Brennan, Gutin, Tabar (bib29) 2018; 83 Yang, Jin, Pang, Huang, Wang, Zhang, Tuo, Wu, Wang, Zhu (bib114) 2020; 11 Zhang, Stevens, Bradshaw (bib117) 2012; 5 Fisher, Reynolds, Von Behren, Carmichael, Rasmussen, Shaw (bib32) 2012; 160 Greenop, Peters, Fritschi, Glass, Ashton, Bailey, Scott, Daubenton, de Klerk, Armstrong, Milne (bib38) 2014; 25 Lombardi, Caccese, Padovan, Cerretti, Pintacuda, Manara, Di Sarra, Zagonel (bib59) 2021; 13 Nikitovic, Stanic, Pekmezovic, Gazibara, Bokun, Paripovic, Grujicic, Saric, Miskovic (bib70) 2016; 32 Yang, Chen, Sun, Chen, Yang, Ma, Yang (bib115) 2021; 11 Ostrom, Kinnersley, Armstrong, Rice, Chen, Wiencke, McCoy, Hansen, Amos, Bernstein, Claus, Eckel-Passow, Il'yasova, Johansen, Lachance, Lai, Merrell, Olson, Sadetzki, Schildkraut, Shete, Rubin, Andersson, Rajaraman, Chanock, Linet, Wang, Yeager, GliomaScan, Houlston, Jenkins, Wrensch, Melin, Bondy, Barnholtz-Sloan (bib76) 2018; 143 Li, Yu, Lee, Tsang, Krishnan, Weyand, Goronzy (bib55) 2012; 18 Das, K.K. and R. Kumar (2017). Pediatric Glioblastoma. Glioblastoma. S. De Vleeschouwer. Brisbane (AU). Kim, Ladomersky, Mozny, Kocherginsky, O'Shea, Reinstein, Zhai, Bell, Lauing, Bollu, Rabin, Dixit, Kumthekar, Platanias, Hou, Zheng, Wu, Zhang, Hrachova, Merrill, Mrugala, Prabhu, Horbinski, James, Yamini, Ostrom, Johnson, Reardon, Lukas, Wainwright (bib48) 2021; 3 Schwartzentruber, Korshunov, Liu, Jones, Pfaff, Jacob, Sturm, Fontebasso, Quang, Tonjes, Hovestadt, Albrecht, Kool, Nantel, Konermann, Lindroth, Jager, Rausch, Ryzhova, Korbel, Hielscher, Hauser, Garami, Klekner, Bognar, Ebinger, Schuhmann, Scheurlen, Pekrun, Fruhwald, Roggendorf, Kramm, Durken, Atkinson, Lepage, Montpetit, Zakrzewska, Zakrzewski, Liberski, Dong, Siegel, Kulozik, Zapatka, Guha, Malkin, Felsberg, Reifenberger, von Deimling, Ichimura, Collins, Witt, Milde, Witt, Zhang, Castelo-Branco, Lichter, Faury, Tabori, Plass, Majewski, Pfister, Jabado (bib92) 2012; 482 Sun, Warrington, Luo, Brooks, Dahiya, S Cameron (10.1016/j.mad.2023.111801_bib15) 2011; 71 Sasaki (10.1016/j.mad.2023.111801_bib88) 2018; 140 Li (10.1016/j.mad.2023.111801_bib57) 2009; 20 Schaefer (10.1016/j.mad.2023.111801_bib89) 2005; 92 Sun (10.1016/j.mad.2023.111801_bib97) 2014; 124 Fisher (10.1016/j.mad.2023.111801_bib32) 2012; 160 Abou-Elkacem (10.1016/j.mad.2023.111801_bib1) 2013; 12 Toledo (10.1016/j.mad.2023.111801_bib102) 2017; 130 Cloughesy (10.1016/j.mad.2023.111801_bib19) 2019; 25 Taylor (10.1016/j.mad.2023.111801_bib100) 2012; 12 Tsien (10.1016/j.mad.2023.111801_bib104) 2009; 73 Louis (10.1016/j.mad.2023.111801_bib61) 2021; 23 Ozawa (10.1016/j.mad.2023.111801_bib80) 2019; 9 Walker (10.1016/j.mad.2023.111801_bib106) 1978; 49 Cohen (10.1016/j.mad.2023.111801_bib20) 2011; 13 Fitzek (10.1016/j.mad.2023.111801_bib33) 1999; 91 10.1016/j.mad.2023.111801_bib71 Wang (10.1016/j.mad.2023.111801_bib107) 2022; 13 M (10.1016/j.mad.2023.111801_bib62) 2018; 140 Bilello (10.1016/j.mad.2023.111801_bib8) 2016; 12 Greenop (10.1016/j.mad.2023.111801_bib38) 2014; 25 Mackay (10.1016/j.mad.2023.111801_bib63) 2017; 32 Broestl (10.1016/j.mad.2023.111801_bib14) 2021; 162 Li (10.1016/j.mad.2023.111801_bib55) 2012; 18 Schwartzbaum (10.1016/j.mad.2023.111801_bib91) 2012; 104 Iacob (10.1016/j.mad.2023.111801_bib42) 2009; 2 Wilhelm (10.1016/j.mad.2023.111801_bib108) 2011; 129 Solomon (10.1016/j.mad.2023.111801_bib94) 2016; 26 Peters (10.1016/j.mad.2023.111801_bib84) 2013; 132 Lombardi (10.1016/j.mad.2023.111801_bib59) 2021; 13 Malbec (10.1016/j.mad.2023.111801_bib64) 2007; 178 Patil (10.1016/j.mad.2023.111801_bib82) 2021; 23 Zawlik (10.1016/j.mad.2023.111801_bib116) 2009; 32 Hanif (10.1016/j.mad.2023.111801_bib40) 2017; 18 Khuong-Quang (10.1016/j.mad.2023.111801_bib47) 2012; 124 Wisoff (10.1016/j.mad.2023.111801_bib109) 1998; 89 Brodbelt (10.1016/j.mad.2023.111801_bib13) 2015; 51 Fyllingen (10.1016/j.mad.2023.111801_bib36) 2021; 163 Ostrom (10.1016/j.mad.2023.111801_bib78) 2019; 21 Yang (10.1016/j.mad.2023.111801_bib113) 2019; 11 Lombardi (10.1016/j.mad.2023.111801_bib58) 2019; 20 Ostrom (10.1016/j.mad.2023.111801_bib76) 2018; 143 Gao (10.1016/j.mad.2023.111801_bib37) 2013; 6 Sim (10.1016/j.mad.2023.111801_bib93) 2018; 7 Bausart (10.1016/j.mad.2023.111801_bib7) 2022; 41 Schreck (10.1016/j.mad.2023.111801_bib90) 2019; 143 Ladomersky (10.1016/j.mad.2023.111801_bib52) 2019; 10 Malmer (10.1016/j.mad.2023.111801_bib65) 2003; 106 Nikitovic (10.1016/j.mad.2023.111801_bib70) 2016; 32 Pearson (10.1016/j.mad.2023.111801_bib83) 2017; 2 Grill (10.1016/j.mad.2023.111801_bib39) 2018; 36 Kleihues (10.1016/j.mad.2023.111801_bib49) 1993; 3 Schwartzentruber (10.1016/j.mad.2023.111801_bib92) 2012; 482 Yang (10.1016/j.mad.2023.111801_bib112) 2022; 21 Pacifici (10.1016/j.mad.2023.111801_bib81) 2016; 27 Chatwin (10.1016/j.mad.2023.111801_bib17) 2021; 288 Fukai (10.1016/j.mad.2023.111801_bib34) 2020; 37 Mizumoto (10.1016/j.mad.2023.111801_bib68) 2015; 5 Ladomersky (10.1016/j.mad.2023.111801_bib53) 2020; 26 Bailey (10.1016/j.mad.2023.111801_bib4) 2017; 140 Louis (10.1016/j.mad.2023.111801_bib60) 2016; 131 Alhalaseh (10.1016/j.mad.2023.111801_bib3) 2021; 73 Vanan (10.1016/j.mad.2023.111801_bib105) 2014; 1 Wu (10.1016/j.mad.2023.111801_bib111) 2017; 22 McKinnon (10.1016/j.mad.2023.111801_bib66) 2021; 374 Baumann (10.1016/j.mad.2023.111801_bib6) 2020; 146 Ostrom (10.1016/j.mad.2023.111801_bib73) 2016; 18 10.1016/j.mad.2023.111801_bib24 Yang (10.1016/j.mad.2023.111801_bib114) 2020; 11 Adams (10.1016/j.mad.2023.111801_bib2) 2016; 32 Reardon (10.1016/j.mad.2023.111801_bib86) 2020; 6 Wolff (10.1016/j.mad.2023.111801_bib110) 2010; 116 Bray (10.1016/j.mad.2023.111801_bib11) 2018; 68 Furnari (10.1016/j.mad.2023.111801_bib35) 2007; 21 Bains (10.1016/j.mad.2023.111801_bib5) 2009; 113 Esquenazi (10.1016/j.mad.2023.111801_bib29) 2018; 83 Thakkar (10.1016/j.mad.2023.111801_bib101) 2014; 23 Finlay (10.1016/j.mad.2023.111801_bib31) 1995; 13 Lehrer (10.1016/j.mad.2023.111801_bib54) 2019; 177 Cordier (10.1016/j.mad.2023.111801_bib21) 2004; 159 Khan (10.1016/j.mad.2023.111801_bib46) 2021; 11 Tamimi (10.1016/j.mad.2023.111801_bib98) 2017 Dunkel (10.1016/j.mad.2023.111801_bib28) 2022; 24 Kfoury (10.1016/j.mad.2023.111801_bib45) 2018; 6 Ostrom (10.1016/j.mad.2023.111801_bib77) 2019; 21 Stupp (10.1016/j.mad.2023.111801_bib95) 2005; 352 Ettrich (10.1016/j.mad.2023.111801_bib30) 2018; 211 Yang (10.1016/j.mad.2023.111801_bib115) 2021; 11 Huang (10.1016/j.mad.2023.111801_bib41) 2020; 11 Mizumoto (10.1016/j.mad.2023.111801_bib69) 2017; 57 Trone (10.1016/j.mad.2023.111801_bib103) 2020; 15 Kim (10.1016/j.mad.2023.111801_bib48) 2021; 3 Kanderi (10.1016/j.mad.2023.111801_bib44) 2022 Blumenthal (10.1016/j.mad.2023.111801_bib9) 2016; 129 Tan (10.1016/j.mad.2023.111801_bib99) 2020; 70 Chakrabarti (10.1016/j.mad.2023.111801_bib16) 2005; 104 Chieffo (10.1016/j.mad.2023.111801_bib18) 2014; 13 Dobran (10.1016/j.mad.2023.111801_bib27) 2018; 58 Ohgaki (10.1016/j.mad.2023.111801_bib72) 2013; 19 Daudigeos-Dubus (10.1016/j.mad.2023.111801_bib25) 2015; 10 Santosh (10.1016/j.mad.2023.111801_bib87) 2022; 65 Su (10.1016/j.mad.2023.111801_bib96) 2020; 67 Brandes (10.1016/j.mad.2023.111801_bib10) 2008; 67 Jiang (10.1016/j.mad.2023.111801_bib43) 2013; 8 Ostrom (10.1016/j.mad.2023.111801_bib75) 2018; 20 Ostrom (10.1016/j.mad.2023.111801_bib79) 2021; 23 Press (10.1016/j.mad.2023.111801_bib85) 2020; 126 Das (10.1016/j.mad.2023.111801_bib23) 2012; 28 Zhang (10.1016/j.mad.2023.111801_bib117) 2012; 5 Ostrom (10.1016/j.mad.2023.111801_bib74) 2018; 8 Mizumoto (10.1016/j.mad.2023.111801_bib67) 2010; 77 Detti (10.1016/j.mad.2023.111801_bib26) 2021; 126 Konig (10.1016/j.mad.2023.111801_bib50) 2021; 16 Li (10.1016/j.mad.2023.111801_bib56) 2018; 112 Brennan (10.1016/j.mad.2023.111801_bib12) 2013; 155 D'Alessio (10.1016/j.mad.2023.111801_bib22) 2019; 11 Korshunov (10.1016/j.mad.2023.111801_bib51) 2015; 129 |
References_xml | – volume: 8 year: 2013 ident: bib43 article-title: Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies publication-title: PLoS One – volume: 32 start-page: 493 year: 2016 end-page: 503 ident: bib2 article-title: Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis publication-title: Childs Nerv. Syst. – volume: 23 start-page: 990 year: 2021 end-page: 998 ident: bib82 article-title: Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017 publication-title: Neuro Oncol. – volume: 41 start-page: 35 year: 2022 ident: bib7 article-title: Immunotherapy for glioblastoma: the promise of combination strategies publication-title: J. Exp. Clin. Cancer Res – volume: 23 start-page: 1985 year: 2014 end-page: 1996 ident: bib101 article-title: Epidemiologic and molecular prognostic review of glioblastoma publication-title: Cancer Epidemiol. Biomark. Prev. – volume: 3 start-page: 255 year: 1993 end-page: 268 ident: bib49 article-title: The new WHO classification of brain tumours publication-title: Brain Pathol. – volume: 15 start-page: 145 year: 2020 ident: bib103 article-title: Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis publication-title: Radiat. Oncol. – volume: 32 start-page: 21 year: 2009 end-page: 29 ident: bib116 article-title: Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study publication-title: Neuroepidemiology – volume: 71 start-page: 1093 year: 2011 end-page: 1104 ident: bib15 article-title: Ipilimumab: first global approval publication-title: Drugs – volume: 104 start-page: 1251 year: 2012 end-page: 1259 ident: bib91 article-title: Association between prediagnostic IgE levels and risk of glioma publication-title: J. Natl. Cancer Inst. – volume: 92 start-page: 913 year: 2005 end-page: 920 ident: bib89 article-title: Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer publication-title: Br. J. Cancer – volume: 11 year: 2021 ident: bib46 article-title: Identification of gender-specific molecular differences in glioblastoma (GBM) and low-grade glioma (LGG) by the analysis of large transcriptomic and epigenomic datasets publication-title: Front. Oncol. – volume: 162 year: 2021 ident: bib14 article-title: Sexual differentiation specifies cellular responses to DNA damage publication-title: Endocrinology – volume: 23 start-page: 1231 year: 2021 end-page: 1251 ident: bib61 article-title: The 2021 WHO classification of tumors of the central nervous system: a summary publication-title: Neuro Oncol. – volume: 24 start-page: i82 year: 2022 end-page: i83 ident: bib28 article-title: Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908 publication-title: Neuro-Oncol. – volume: 26 start-page: 5232 year: 2020 end-page: 5245 ident: bib53 article-title: Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma publication-title: Clin. Cancer Res. – volume: 11 start-page: 19493 year: 2021 ident: bib115 article-title: Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas publication-title: Sci. Rep. – volume: 25 start-page: 477 year: 2019 end-page: 486 ident: bib19 article-title: Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma publication-title: Nat. Med. – volume: 155 start-page: 462 year: 2013 end-page: 477 ident: bib12 article-title: The somatic genomic landscape of glioblastoma publication-title: Cell – volume: 5 start-page: e9 year: 2015 end-page: e16 ident: bib68 article-title: Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy publication-title: Pract. Radiat. Oncol. – volume: 91 start-page: 251 year: 1999 end-page: 260 ident: bib33 article-title: Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial publication-title: J. Neurosurg. – volume: 12 start-page: 1322 year: 2013 end-page: 1331 ident: bib1 article-title: Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model publication-title: Mol. Cancer Ther. – volume: 106 start-page: 260 year: 2003 end-page: 263 ident: bib65 article-title: Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients publication-title: Int. J. Cancer – volume: 89 start-page: 52 year: 1998 end-page: 59 ident: bib109 article-title: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945 publication-title: J. Neurosurg. – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib11 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. – volume: 13 start-page: 7223 year: 2022 ident: bib107 article-title: Genomic disparities between cancers in adolescent and young adults and in older adults publication-title: Nat. Commun. – volume: 6 start-page: 1003 year: 2020 end-page: 1010 ident: bib86 article-title: Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial publication-title: JAMA Oncol. – volume: 1 start-page: 145 year: 2014 end-page: 157 ident: bib105 article-title: Management of high-grade gliomas in the pediatric patient: Past, present, and future publication-title: Neurooncol. Pract. – volume: 83 start-page: 76 year: 2018 end-page: 85 ident: bib29 article-title: Thalamic glioblastoma: clinical presentation, management strategies, and outcomes publication-title: Neurosurgery – volume: 20 start-page: 945 year: 2009 end-page: 955 ident: bib57 article-title: Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer in the offspring publication-title: Cancer Causes Control – year: 2022 ident: bib44 article-title: Glioblastoma Multiforme – volume: 67 year: 2020 ident: bib96 article-title: A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma publication-title: Pedia Blood Cancer – volume: 3 year: 2021 ident: bib48 article-title: Glioblastoma as an age-related neurological disorder in adults publication-title: Neurooncol. Adv. – volume: 211 start-page: 45 year: 2018 end-page: 56 ident: bib30 article-title: Regorafenib publication-title: Recent Results Cancer Res. – volume: 20 start-page: 576 year: 2018 end-page: 577 ident: bib75 article-title: Females have the survival advantage in glioblastoma publication-title: Neuro Oncol. – volume: 11 year: 2019 ident: bib113 article-title: Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data publication-title: Sci. Transl. Med. – volume: 19 start-page: 764 year: 2013 end-page: 772 ident: bib72 article-title: The definition of primary and secondary glioblastoma publication-title: Clin. Cancer Res. – reference: Das, K.K. and R. Kumar (2017). Pediatric Glioblastoma. Glioblastoma. S. De Vleeschouwer. Brisbane (AU). – volume: 146 start-page: 63 year: 2020 end-page: 69 ident: bib6 article-title: Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation publication-title: J. Neurooncol – volume: 58 start-page: 110 year: 2018 end-page: 115 ident: bib27 article-title: Prognostic factors in glioblastoma: is there a role for epilepsy? publication-title: Neurol. Med. Chir. – volume: 11 year: 2020 ident: bib41 article-title: Current immunotherapies for glioblastoma multiforme publication-title: Front. Immunol. – volume: 65 start-page: S14 year: 2022 end-page: S23 ident: bib87 article-title: A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted publication-title: Indian J. Pathol. Microbiol. – volume: 12 start-page: 197 year: 2012 end-page: 209 ident: bib100 article-title: Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance publication-title: Curr. Cancer Drug Targets – volume: 160 start-page: 978 year: 2012 end-page: 983 ident: bib32 article-title: Cancer in children with nonchromosomal birth defects publication-title: J. Pedia – volume: 2 start-page: 17040 year: 2017 ident: bib83 article-title: Targeting cellular pathways in glioblastoma multiforme publication-title: Signal Transduct. Target. Ther. – volume: 352 start-page: 987 year: 2005 end-page: 996 ident: bib95 article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma publication-title: New Engl. J. Med. – volume: 22 start-page: 1805 year: 2017 end-page: 1829 ident: bib111 article-title: The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease publication-title: Front. Biosci. – volume: 126 start-page: 3255 year: 2020 end-page: 3264 ident: bib85 article-title: Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification publication-title: Cancer – volume: 288 start-page: 6127 year: 2021 end-page: 6141 ident: bib17 article-title: Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy publication-title: FEBS J. – volume: 20 start-page: 110 year: 2019 end-page: 119 ident: bib58 article-title: Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial publication-title: Lancet Oncol. – volume: 26 start-page: 569 year: 2016 end-page: 580 ident: bib94 article-title: Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations publication-title: Brain Pathol. – volume: 159 start-page: 1109 year: 2004 end-page: 1116 ident: bib21 article-title: Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: The SEARCH International Childhood Brain Tumor Study publication-title: Am. J. Epidemiol. – volume: 140 start-page: 329 year: 2018 end-page: 339 ident: bib88 article-title: Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai molecular diagnosis network for CNS tumors publication-title: J. Neurooncol. – volume: 113 start-page: 5480 year: 2009 end-page: 5487 ident: bib5 article-title: Quantifying the development of the peripheral naive CD4+ T-cell pool in humans publication-title: Blood – volume: 23 year: 2021 ident: bib79 article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018 publication-title: Neuro Oncol. – volume: 163 start-page: 1895 year: 2021 end-page: 1905 ident: bib36 article-title: Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort publication-title: Acta Neurochir. – volume: 21 start-page: v1 year: 2019 end-page: v100 ident: bib77 article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016 publication-title: Neuro Oncol. – volume: 21 start-page: 1357 year: 2019 end-page: 1375 ident: bib78 article-title: Risk factors for childhood and adult primary brain tumors publication-title: Neuro Oncol. – volume: 143 start-page: 2359 year: 2018 end-page: 2366 ident: bib76 article-title: Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age publication-title: Int. J. Cancer – volume: 9 year: 2019 ident: bib80 article-title: The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014) publication-title: BMJ Open – volume: 116 start-page: 705 year: 2010 end-page: 712 ident: bib110 article-title: Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol publication-title: Cancer – volume: 21 start-page: 2683 year: 2007 end-page: 2710 ident: bib35 article-title: Malignant astrocytic glioma: genetics, biology, and paths to treatment publication-title: Genes Dev. – volume: 6 start-page: 12 year: 2018 ident: bib45 article-title: Cooperative p16 and p21 action protects female astrocytes from transformation publication-title: Acta Neuropathol. Commun. – volume: 57 start-page: 343 year: 2017 end-page: 355 ident: bib69 article-title: Proton beam therapy for pediatric brain tumor publication-title: Neurol. Med. Chir. – volume: 28 start-page: 2055 year: 2012 end-page: 2062 ident: bib23 article-title: Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome publication-title: Childs Nerv. Syst. – volume: 36 start-page: 951 year: 2018 end-page: 958 ident: bib39 article-title: Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma publication-title: J. Clin. Oncol. – volume: 129 start-page: 245 year: 2011 end-page: 255 ident: bib108 article-title: Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity publication-title: Int. J. Cancer – volume: 124 start-page: 4123 year: 2014 end-page: 4133 ident: bib97 article-title: Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males publication-title: J. Clin. Invest – volume: 67 start-page: 139 year: 2008 end-page: 152 ident: bib10 article-title: Glioblastoma in adults publication-title: Crit. Rev. Oncol. Hematol. – volume: 482 start-page: 226 year: 2012 end-page: 231 ident: bib92 article-title: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma publication-title: Nature – volume: 7 start-page: 51 year: 2018 end-page: 65 ident: bib93 article-title: Contemporary management of high-grade gliomas publication-title: CNS Oncol. – volume: 32 start-page: 97 year: 2016 end-page: 103 ident: bib70 article-title: Pediatric glioblastoma: a single institution experience publication-title: Childs Nerv. Syst. – volume: 27 start-page: 93 year: 2016 end-page: 104 ident: bib81 article-title: Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders publication-title: Cytokine Growth Factor Rev. – volume: 11 start-page: 40 year: 2020 ident: bib114 article-title: Comparative efficacy and safety of nivolumab and nivolumab plus ipilimumab in advanced cancer: a systematic review and meta-analysis publication-title: Front Pharmacol. – volume: 140 start-page: 485 year: 2018 end-page: 496 ident: bib62 article-title: Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review publication-title: J. Neurooncol. – volume: 18 start-page: 3 year: 2017 end-page: 9 ident: bib40 article-title: Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment publication-title: Asian Pac. J. Cancer Prev. – volume: 178 start-page: 6465 year: 2007 end-page: 6475 ident: bib64 article-title: Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells publication-title: J. Immunol. – volume: 70 start-page: 299 year: 2020 end-page: 312 ident: bib99 article-title: Management of glioblastoma: state of the art and future directions publication-title: CA Cancer J. Clin. – volume: 140 start-page: 1757 year: 2017 end-page: 1769 ident: bib4 article-title: Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France) publication-title: Int. J. Cancer – volume: 8 start-page: 7352 year: 2018 ident: bib74 article-title: Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 publication-title: Sci. Rep. – volume: 132 start-page: 2975 year: 2013 end-page: 2979 ident: bib84 article-title: Parental occupational exposure to engine exhausts and childhood brain tumors publication-title: Int J. Cancer – volume: 13 start-page: 112 year: 1995 end-page: 123 ident: bib31 article-title: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens cancer group publication-title: J. Clin. Oncol. – year: 2017 ident: bib98 article-title: Epidemiology and outcome of glioblastoma publication-title: Glioblastoma – volume: 73 year: 2021 ident: bib3 article-title: Glioblastoma in adolescents and young adults: an age-based comparative study from Jordan over a 17-year period publication-title: Cancer Epidemiol. – volume: 131 start-page: 803 year: 2016 end-page: 820 ident: bib60 article-title: The 2016 World Health Organization classification of tumors of the central nervous system: a summary publication-title: Acta Neuropathol. – reference: (5): 510–522. – volume: 77 start-page: 98 year: 2010 end-page: 105 ident: bib67 article-title: Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme publication-title: Int J. Radiat. Oncol. Biol. Phys. – volume: 126 start-page: 1249 year: 2021 end-page: 1254 ident: bib26 article-title: Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients publication-title: Radiol. Med. – volume: 37 start-page: 50 year: 2020 end-page: 59 ident: bib34 article-title: Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort publication-title: Brain Tumor Pathol. – volume: 124 start-page: 439 year: 2012 end-page: 447 ident: bib47 article-title: K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas publication-title: Acta Neuropathol. – reference: Noushmehr, H., D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape and N. Cancer Genome Atlas Research (2010). "Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma." Cancer Cell – volume: 25 start-page: 283 year: 2014 end-page: 291 ident: bib38 article-title: Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control study publication-title: Cancer Causes Control – volume: 177 start-page: 63 year: 2019 end-page: 67 ident: bib54 article-title: Allergy may confer better survival on patients with gliomas publication-title: Clin. Neurol. Neurosurg. – volume: 51 start-page: 533 year: 2015 end-page: 542 ident: bib13 article-title: Glioblastoma in England: 2007-2011 publication-title: Eur. J. Cancer – volume: 32 start-page: 520 year: 2017 end-page: 537 ident: bib63 article-title: Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma publication-title: Cancer Cell – volume: 13 start-page: 317 year: 2011 end-page: 323 ident: bib20 article-title: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group publication-title: Neuro Oncol. – volume: 11 year: 2019 ident: bib22 article-title: Pathological and molecular features of glioblastoma and its peritumoral tissue publication-title: Cancers – volume: 6 start-page: pl1 year: 2013 ident: bib37 article-title: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal publication-title: Sci. Signal. – volume: 129 start-page: 669 year: 2015 end-page: 678 ident: bib51 article-title: Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers publication-title: Acta Neuropathol. – volume: 112 start-page: e407 year: 2018 end-page: e414 ident: bib56 article-title: Correlation between tumor location and clinical properties of glioblastomas in frontal and temporal lobes publication-title: World Neurosurg. – volume: 16 start-page: 240 year: 2021 ident: bib50 article-title: Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study publication-title: Radiat. Oncol. – volume: 10 start-page: 200 year: 2019 ident: bib52 article-title: The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma publication-title: Front. Pharmacol. – volume: 21 start-page: 39 year: 2022 ident: bib112 article-title: Glioma targeted therapy: insight into future of molecular approaches publication-title: Mol. Cancer – volume: 73 start-page: 699 year: 2009 end-page: 708 ident: bib104 article-title: Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: radiation therapy oncology group trial 98-03 publication-title: Int J. Radiat. Oncol. Biol. Phys. – volume: 374 start-page: n1560 year: 2021 ident: bib66 article-title: Glioblastoma: clinical presentation, diagnosis, and management publication-title: BMJ – volume: 104 start-page: 2798 year: 2005 end-page: 2806 ident: bib16 article-title: A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999 publication-title: Cancer – volume: 129 start-page: 453 year: 2016 end-page: 460 ident: bib9 article-title: Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors publication-title: J Neurooncol – volume: 13 start-page: 507 year: 2014 end-page: 513 ident: bib18 article-title: Preoperative neuropsychological and behavioral evaluation of children with thalamic tumors publication-title: J. Neurosurg. Pedia – volume: 12 start-page: 34 year: 2016 end-page: 40 ident: bib8 article-title: Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma publication-title: Neuroimage Clin. – volume: 130 start-page: 1 year: 2017 end-page: 6 ident: bib102 article-title: Epileptic features and survival in glioblastomas presenting with seizures publication-title: Epilepsy Res. – volume: 18 start-page: 1518 year: 2012 end-page: 1524 ident: bib55 article-title: Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity publication-title: Nat. Med. – volume: 143 start-page: 87 year: 2019 end-page: 93 ident: bib90 article-title: Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas publication-title: J. Neurooncol. – volume: 18 start-page: v1 year: 2016 end-page: v75 ident: bib73 article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013 publication-title: Neuro Oncol. – volume: 10 year: 2015 ident: bib25 article-title: Regorafenib: antitumor activity upon mono and combination therapy in preclinical pediatric malignancy models publication-title: PLoS One – volume: 13 year: 2021 ident: bib59 article-title: Regorafenib in recurrent glioblastoma patients: a large and monocentric real-life study publication-title: Cancers – volume: 49 start-page: 333 year: 1978 end-page: 343 ident: bib106 article-title: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial publication-title: J. Neurosurg. – volume: 5 start-page: 102 year: 2012 end-page: 114 ident: bib117 article-title: "Temozolomide: mechanisms of action, repair and resistance." publication-title: Curr. Mol. Pharm. – volume: 2 start-page: 386 year: 2009 end-page: 393 ident: bib42 article-title: Current data and strategy in glioblastoma multiforme publication-title: J. Med. Life – volume: 482 start-page: 226 issue: 7384 year: 2012 ident: 10.1016/j.mad.2023.111801_bib92 article-title: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma publication-title: Nature doi: 10.1038/nature10833 – volume: 41 start-page: 35 issue: 1 year: 2022 ident: 10.1016/j.mad.2023.111801_bib7 article-title: Immunotherapy for glioblastoma: the promise of combination strategies publication-title: J. Exp. Clin. Cancer Res doi: 10.1186/s13046-022-02251-2 – volume: 8 start-page: 7352 issue: 1 year: 2018 ident: 10.1016/j.mad.2023.111801_bib74 article-title: Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 publication-title: Sci. Rep. doi: 10.1038/s41598-018-24580-z – volume: 58 start-page: 110 issue: 3 year: 2018 ident: 10.1016/j.mad.2023.111801_bib27 article-title: Prognostic factors in glioblastoma: is there a role for epilepsy? publication-title: Neurol. Med. Chir. doi: 10.2176/nmc.oa.2017-0167 – volume: 131 start-page: 803 issue: 6 year: 2016 ident: 10.1016/j.mad.2023.111801_bib60 article-title: The 2016 World Health Organization classification of tumors of the central nervous system: a summary publication-title: Acta Neuropathol. doi: 10.1007/s00401-016-1545-1 – volume: 374 start-page: n1560 year: 2021 ident: 10.1016/j.mad.2023.111801_bib66 article-title: Glioblastoma: clinical presentation, diagnosis, and management publication-title: BMJ doi: 10.1136/bmj.n1560 – volume: 7 start-page: 51 issue: 1 year: 2018 ident: 10.1016/j.mad.2023.111801_bib93 article-title: Contemporary management of high-grade gliomas publication-title: CNS Oncol. doi: 10.2217/cns-2017-0026 – volume: 21 start-page: v1 issue: 5 year: 2019 ident: 10.1016/j.mad.2023.111801_bib77 article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016 publication-title: Neuro Oncol. doi: 10.1093/neuonc/noz150 – volume: 162 issue: 11 year: 2021 ident: 10.1016/j.mad.2023.111801_bib14 article-title: Sexual differentiation specifies cellular responses to DNA damage publication-title: Endocrinology doi: 10.1210/endocr/bqab192 – volume: 65 start-page: S14 year: 2022 ident: 10.1016/j.mad.2023.111801_bib87 article-title: A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted publication-title: Indian J. Pathol. Microbiol. – volume: 352 start-page: 987 issue: 10 year: 2005 ident: 10.1016/j.mad.2023.111801_bib95 article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa043330 – volume: 9 issue: 8 year: 2019 ident: 10.1016/j.mad.2023.111801_bib80 article-title: The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014) publication-title: BMJ Open doi: 10.1136/bmjopen-2019-029686 – volume: 3 start-page: 255 issue: 3 year: 1993 ident: 10.1016/j.mad.2023.111801_bib49 article-title: The new WHO classification of brain tumours publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.1993.tb00752.x – volume: 26 start-page: 5232 issue: 19 year: 2020 ident: 10.1016/j.mad.2023.111801_bib53 article-title: Advanced age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-19-3874 – volume: 124 start-page: 439 issue: 3 year: 2012 ident: 10.1016/j.mad.2023.111801_bib47 article-title: K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas publication-title: Acta Neuropathol. doi: 10.1007/s00401-012-0998-0 – volume: 155 start-page: 462 issue: 2 year: 2013 ident: 10.1016/j.mad.2023.111801_bib12 article-title: The somatic genomic landscape of glioblastoma publication-title: Cell doi: 10.1016/j.cell.2013.09.034 – year: 2017 ident: 10.1016/j.mad.2023.111801_bib98 article-title: Epidemiology and outcome of glioblastoma – volume: 8 issue: 1 year: 2013 ident: 10.1016/j.mad.2023.111801_bib43 article-title: Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies publication-title: PLoS One doi: 10.1371/journal.pone.0055597 – volume: 5 start-page: e9 issue: 1 year: 2015 ident: 10.1016/j.mad.2023.111801_bib68 article-title: Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy publication-title: Pract. Radiat. Oncol. doi: 10.1016/j.prro.2014.03.012 – volume: 16 start-page: 240 issue: 1 year: 2021 ident: 10.1016/j.mad.2023.111801_bib50 publication-title: Radiat. Oncol. doi: 10.1186/s13014-021-01962-8 – volume: 140 start-page: 329 issue: 2 year: 2018 ident: 10.1016/j.mad.2023.111801_bib88 article-title: Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai molecular diagnosis network for CNS tumors publication-title: J. Neurooncol. doi: 10.1007/s11060-018-2957-7 – volume: 91 start-page: 251 issue: 2 year: 1999 ident: 10.1016/j.mad.2023.111801_bib33 article-title: Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial publication-title: J. Neurosurg. doi: 10.3171/jns.1999.91.2.0251 – volume: 132 start-page: 2975 issue: 12 year: 2013 ident: 10.1016/j.mad.2023.111801_bib84 article-title: Parental occupational exposure to engine exhausts and childhood brain tumors publication-title: Int J. Cancer doi: 10.1002/ijc.27972 – volume: 5 start-page: 102 issue: 1 year: 2012 ident: 10.1016/j.mad.2023.111801_bib117 article-title: "Temozolomide: mechanisms of action, repair and resistance." publication-title: Curr. Mol. Pharm. doi: 10.2174/1874467211205010102 – volume: 13 start-page: 112 issue: 1 year: 1995 ident: 10.1016/j.mad.2023.111801_bib31 article-title: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens cancer group publication-title: J. Clin. Oncol. doi: 10.1200/JCO.1995.13.1.112 – volume: 112 start-page: e407 year: 2018 ident: 10.1016/j.mad.2023.111801_bib56 article-title: Correlation between tumor location and clinical properties of glioblastomas in frontal and temporal lobes publication-title: World Neurosurg. doi: 10.1016/j.wneu.2018.01.055 – volume: 23 issue: 2 year: 2021 ident: 10.1016/j.mad.2023.111801_bib79 article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018 publication-title: Neuro Oncol. – volume: 11 year: 2021 ident: 10.1016/j.mad.2023.111801_bib46 article-title: Identification of gender-specific molecular differences in glioblastoma (GBM) and low-grade glioma (LGG) by the analysis of large transcriptomic and epigenomic datasets publication-title: Front. Oncol. doi: 10.3389/fonc.2021.699594 – volume: 77 start-page: 98 issue: 1 year: 2010 ident: 10.1016/j.mad.2023.111801_bib67 article-title: Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme publication-title: Int J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2009.04.054 – volume: 83 start-page: 76 issue: 1 year: 2018 ident: 10.1016/j.mad.2023.111801_bib29 article-title: Thalamic glioblastoma: clinical presentation, management strategies, and outcomes publication-title: Neurosurgery doi: 10.1093/neuros/nyx349 – volume: 13 issue: 18 year: 2021 ident: 10.1016/j.mad.2023.111801_bib59 article-title: Regorafenib in recurrent glioblastoma patients: a large and monocentric real-life study publication-title: Cancers doi: 10.3390/cancers13184731 – volume: 37 start-page: 50 issue: 2 year: 2020 ident: 10.1016/j.mad.2023.111801_bib34 article-title: Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort publication-title: Brain Tumor Pathol. doi: 10.1007/s10014-020-00363-1 – volume: 143 start-page: 2359 issue: 10 year: 2018 ident: 10.1016/j.mad.2023.111801_bib76 article-title: Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age publication-title: Int. J. Cancer doi: 10.1002/ijc.31759 – volume: 32 start-page: 97 issue: 1 year: 2016 ident: 10.1016/j.mad.2023.111801_bib70 article-title: Pediatric glioblastoma: a single institution experience publication-title: Childs Nerv. Syst. doi: 10.1007/s00381-015-2945-6 – volume: 57 start-page: 343 issue: 7 year: 2017 ident: 10.1016/j.mad.2023.111801_bib69 article-title: Proton beam therapy for pediatric brain tumor publication-title: Neurol. Med. Chir. doi: 10.2176/nmc.ra.2017-0003 – volume: 288 start-page: 6127 issue: 21 year: 2021 ident: 10.1016/j.mad.2023.111801_bib17 article-title: Pediatric high-grade glioma: moving toward subtype-specific multimodal therapy publication-title: FEBS J. doi: 10.1111/febs.15739 – volume: 13 start-page: 317 issue: 3 year: 2011 ident: 10.1016/j.mad.2023.111801_bib20 article-title: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group publication-title: Neuro Oncol. doi: 10.1093/neuonc/noq191 – volume: 49 start-page: 333 issue: 3 year: 1978 ident: 10.1016/j.mad.2023.111801_bib106 article-title: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial publication-title: J. Neurosurg. doi: 10.3171/jns.1978.49.3.0333 – volume: 129 start-page: 453 year: 2016 ident: 10.1016/j.mad.2023.111801_bib9 article-title: Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors publication-title: J Neurooncol doi: 10.1007/s11060-016-2190-1 – volume: 18 start-page: v1 issue: 5 year: 2016 ident: 10.1016/j.mad.2023.111801_bib73 article-title: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013 publication-title: Neuro Oncol. doi: 10.1093/neuonc/now207 – volume: 12 start-page: 34 year: 2016 ident: 10.1016/j.mad.2023.111801_bib8 article-title: Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma publication-title: Neuroimage Clin. doi: 10.1016/j.nicl.2016.03.007 – volume: 11 year: 2020 ident: 10.1016/j.mad.2023.111801_bib41 article-title: Current immunotherapies for glioblastoma multiforme publication-title: Front. Immunol. – ident: 10.1016/j.mad.2023.111801_bib71 doi: 10.1016/j.ccr.2010.03.017 – volume: 11 start-page: 40 year: 2020 ident: 10.1016/j.mad.2023.111801_bib114 article-title: Comparative efficacy and safety of nivolumab and nivolumab plus ipilimumab in advanced cancer: a systematic review and meta-analysis publication-title: Front Pharmacol. doi: 10.3389/fphar.2020.00040 – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 10.1016/j.mad.2023.111801_bib11 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21492 – volume: 67 start-page: 139 issue: 2 year: 2008 ident: 10.1016/j.mad.2023.111801_bib10 article-title: Glioblastoma in adults publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2008.02.005 – volume: 32 start-page: 21 issue: 1 year: 2009 ident: 10.1016/j.mad.2023.111801_bib116 article-title: Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study publication-title: Neuroepidemiology doi: 10.1159/000170088 – volume: 92 start-page: 913 issue: 5 year: 2005 ident: 10.1016/j.mad.2023.111801_bib89 article-title: Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6602407 – volume: 23 start-page: 990 issue: 6 year: 2021 ident: 10.1016/j.mad.2023.111801_bib82 article-title: Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017 publication-title: Neuro Oncol. doi: 10.1093/neuonc/noaa295 – volume: 1 start-page: 145 issue: 4 year: 2014 ident: 10.1016/j.mad.2023.111801_bib105 article-title: Management of high-grade gliomas in the pediatric patient: Past, present, and future publication-title: Neurooncol. Pract. – volume: 124 start-page: 4123 issue: 9 year: 2014 ident: 10.1016/j.mad.2023.111801_bib97 article-title: Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males publication-title: J. Clin. Invest doi: 10.1172/JCI71048 – volume: 11 start-page: 19493 issue: 1 year: 2021 ident: 10.1016/j.mad.2023.111801_bib115 article-title: Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas publication-title: Sci. Rep. doi: 10.1038/s41598-021-98913-w – year: 2022 ident: 10.1016/j.mad.2023.111801_bib44 – volume: 10 start-page: 200 year: 2019 ident: 10.1016/j.mad.2023.111801_bib52 article-title: The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.00200 – volume: 11 issue: 473 year: 2019 ident: 10.1016/j.mad.2023.111801_bib113 article-title: Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aao5253 – volume: 126 start-page: 1249 issue: 9 year: 2021 ident: 10.1016/j.mad.2023.111801_bib26 article-title: Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients publication-title: Radiol. Med. doi: 10.1007/s11547-021-01381-5 – volume: 126 start-page: 3255 issue: 14 year: 2020 ident: 10.1016/j.mad.2023.111801_bib85 article-title: Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification publication-title: Cancer doi: 10.1002/cncr.32797 – volume: 13 start-page: 7223 issue: 1 year: 2022 ident: 10.1016/j.mad.2023.111801_bib107 article-title: Genomic disparities between cancers in adolescent and young adults and in older adults publication-title: Nat. Commun. doi: 10.1038/s41467-022-34959-2 – volume: 12 start-page: 197 issue: 3 year: 2012 ident: 10.1016/j.mad.2023.111801_bib100 article-title: Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance publication-title: Curr. Cancer Drug Targets doi: 10.2174/156800912799277557 – volume: 140 start-page: 1757 issue: 8 year: 2017 ident: 10.1016/j.mad.2023.111801_bib4 article-title: Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France) publication-title: Int. J. Cancer doi: 10.1002/ijc.30597 – volume: 20 start-page: 576 issue: 4 year: 2018 ident: 10.1016/j.mad.2023.111801_bib75 article-title: Females have the survival advantage in glioblastoma publication-title: Neuro Oncol. doi: 10.1093/neuonc/noy002 – volume: 28 start-page: 2055 issue: 12 year: 2012 ident: 10.1016/j.mad.2023.111801_bib23 article-title: Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome publication-title: Childs Nerv. Syst. doi: 10.1007/s00381-012-1890-x – volume: 177 start-page: 63 year: 2019 ident: 10.1016/j.mad.2023.111801_bib54 article-title: Allergy may confer better survival on patients with gliomas publication-title: Clin. Neurol. Neurosurg. doi: 10.1016/j.clineuro.2018.12.021 – volume: 146 start-page: 63 issue: 1 year: 2020 ident: 10.1016/j.mad.2023.111801_bib6 article-title: Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation publication-title: J. Neurooncol doi: 10.1007/s11060-019-03335-4 – volume: 3 issue: 1 year: 2021 ident: 10.1016/j.mad.2023.111801_bib48 article-title: Glioblastoma as an age-related neurological disorder in adults publication-title: Neurooncol. Adv. – volume: 25 start-page: 477 issue: 3 year: 2019 ident: 10.1016/j.mad.2023.111801_bib19 article-title: Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma publication-title: Nat. Med. doi: 10.1038/s41591-018-0337-7 – volume: 10 issue: 11 year: 2015 ident: 10.1016/j.mad.2023.111801_bib25 article-title: Regorafenib: antitumor activity upon mono and combination therapy in preclinical pediatric malignancy models publication-title: PLoS One doi: 10.1371/journal.pone.0142612 – volume: 18 start-page: 3 issue: 1 year: 2017 ident: 10.1016/j.mad.2023.111801_bib40 article-title: Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment publication-title: Asian Pac. J. Cancer Prev. – volume: 13 start-page: 507 issue: 5 year: 2014 ident: 10.1016/j.mad.2023.111801_bib18 article-title: Preoperative neuropsychological and behavioral evaluation of children with thalamic tumors publication-title: J. Neurosurg. Pedia doi: 10.3171/2014.2.PEDS13352 – volume: 21 start-page: 2683 issue: 21 year: 2007 ident: 10.1016/j.mad.2023.111801_bib35 article-title: Malignant astrocytic glioma: genetics, biology, and paths to treatment publication-title: Genes Dev. doi: 10.1101/gad.1596707 – volume: 71 start-page: 1093 issue: 8 year: 2011 ident: 10.1016/j.mad.2023.111801_bib15 article-title: Ipilimumab: first global approval publication-title: Drugs doi: 10.2165/11594010-000000000-00000 – volume: 70 start-page: 299 issue: 4 year: 2020 ident: 10.1016/j.mad.2023.111801_bib99 article-title: Management of glioblastoma: state of the art and future directions publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21613 – volume: 12 start-page: 1322 issue: 7 year: 2013 ident: 10.1016/j.mad.2023.111801_bib1 article-title: Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-12-1162 – volume: 32 start-page: 493 issue: 3 year: 2016 ident: 10.1016/j.mad.2023.111801_bib2 article-title: Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis publication-title: Childs Nerv. Syst. doi: 10.1007/s00381-015-3006-x – volume: 116 start-page: 705 issue: 3 year: 2010 ident: 10.1016/j.mad.2023.111801_bib110 article-title: Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol publication-title: Cancer doi: 10.1002/cncr.24730 – volume: 24 start-page: i82 year: 2022 ident: 10.1016/j.mad.2023.111801_bib28 article-title: Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908 publication-title: Neuro-Oncol. doi: 10.1093/neuonc/noac079.301 – volume: 2 start-page: 386 issue: 4 year: 2009 ident: 10.1016/j.mad.2023.111801_bib42 article-title: Current data and strategy in glioblastoma multiforme publication-title: J. Med. Life – volume: 32 start-page: 520 issue: 4 year: 2017 ident: 10.1016/j.mad.2023.111801_bib63 article-title: Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma publication-title: Cancer Cell doi: 10.1016/j.ccell.2017.08.017 – volume: 106 start-page: 260 issue: 2 year: 2003 ident: 10.1016/j.mad.2023.111801_bib65 article-title: Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients publication-title: Int. J. Cancer doi: 10.1002/ijc.11213 – volume: 26 start-page: 569 issue: 5 year: 2016 ident: 10.1016/j.mad.2023.111801_bib94 article-title: Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations publication-title: Brain Pathol. doi: 10.1111/bpa.12336 – volume: 89 start-page: 52 issue: 1 year: 1998 ident: 10.1016/j.mad.2023.111801_bib109 article-title: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945 publication-title: J. Neurosurg. doi: 10.3171/jns.1998.89.1.0052 – volume: 2 start-page: 17040 year: 2017 ident: 10.1016/j.mad.2023.111801_bib83 article-title: Targeting cellular pathways in glioblastoma multiforme publication-title: Signal Transduct. Target. Ther. doi: 10.1038/sigtrans.2017.40 – volume: 18 start-page: 1518 issue: 10 year: 2012 ident: 10.1016/j.mad.2023.111801_bib55 article-title: Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity publication-title: Nat. Med. doi: 10.1038/nm.2963 – volume: 211 start-page: 45 year: 2018 ident: 10.1016/j.mad.2023.111801_bib30 article-title: Regorafenib publication-title: Recent Results Cancer Res. doi: 10.1007/978-3-319-91442-8_3 – volume: 19 start-page: 764 issue: 4 year: 2013 ident: 10.1016/j.mad.2023.111801_bib72 article-title: The definition of primary and secondary glioblastoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-12-3002 – volume: 6 start-page: pl1 issue: 269 year: 2013 ident: 10.1016/j.mad.2023.111801_bib37 article-title: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal publication-title: Sci. Signal. doi: 10.1126/scisignal.2004088 – volume: 20 start-page: 110 issue: 1 year: 2019 ident: 10.1016/j.mad.2023.111801_bib58 article-title: Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(18)30675-2 – volume: 6 start-page: 12 issue: 1 year: 2018 ident: 10.1016/j.mad.2023.111801_bib45 article-title: Cooperative p16 and p21 action protects female astrocytes from transformation publication-title: Acta Neuropathol. Commun. doi: 10.1186/s40478-018-0513-5 – volume: 27 start-page: 93 year: 2016 ident: 10.1016/j.mad.2023.111801_bib81 article-title: Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2015.12.007 – volume: 73 start-page: 699 issue: 3 year: 2009 ident: 10.1016/j.mad.2023.111801_bib104 article-title: Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: radiation therapy oncology group trial 98-03 publication-title: Int J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2008.05.034 – volume: 113 start-page: 5480 issue: 22 year: 2009 ident: 10.1016/j.mad.2023.111801_bib5 article-title: Quantifying the development of the peripheral naive CD4+ T-cell pool in humans publication-title: Blood doi: 10.1182/blood-2008-10-184184 – volume: 129 start-page: 669 issue: 5 year: 2015 ident: 10.1016/j.mad.2023.111801_bib51 article-title: Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers publication-title: Acta Neuropathol. doi: 10.1007/s00401-015-1405-4 – volume: 159 start-page: 1109 issue: 12 year: 2004 ident: 10.1016/j.mad.2023.111801_bib21 article-title: Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: The SEARCH International Childhood Brain Tumor Study publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwh154 – ident: 10.1016/j.mad.2023.111801_bib24 – volume: 129 start-page: 245 issue: 1 year: 2011 ident: 10.1016/j.mad.2023.111801_bib108 article-title: Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity publication-title: Int. J. Cancer doi: 10.1002/ijc.25864 – volume: 163 start-page: 1895 issue: 7 year: 2021 ident: 10.1016/j.mad.2023.111801_bib36 article-title: Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort publication-title: Acta Neurochir. doi: 10.1007/s00701-021-04802-6 – volume: 6 start-page: 1003 issue: 7 year: 2020 ident: 10.1016/j.mad.2023.111801_bib86 article-title: Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2020.1024 – volume: 178 start-page: 6465 issue: 10 year: 2007 ident: 10.1016/j.mad.2023.111801_bib64 article-title: Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells publication-title: J. Immunol. doi: 10.4049/jimmunol.178.10.6465 – volume: 130 start-page: 1 year: 2017 ident: 10.1016/j.mad.2023.111801_bib102 article-title: Epileptic features and survival in glioblastomas presenting with seizures publication-title: Epilepsy Res. doi: 10.1016/j.eplepsyres.2016.12.013 – volume: 51 start-page: 533 issue: 4 year: 2015 ident: 10.1016/j.mad.2023.111801_bib13 article-title: Glioblastoma in England: 2007-2011 publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2014.12.014 – volume: 160 start-page: 978 issue: 6 year: 2012 ident: 10.1016/j.mad.2023.111801_bib32 article-title: Cancer in children with nonchromosomal birth defects publication-title: J. Pedia doi: 10.1016/j.jpeds.2011.12.006 – volume: 23 start-page: 1231 issue: 8 year: 2021 ident: 10.1016/j.mad.2023.111801_bib61 article-title: The 2021 WHO classification of tumors of the central nervous system: a summary publication-title: Neuro Oncol. doi: 10.1093/neuonc/noab106 – volume: 104 start-page: 2798 issue: 12 year: 2005 ident: 10.1016/j.mad.2023.111801_bib16 article-title: A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999 publication-title: Cancer doi: 10.1002/cncr.21539 – volume: 36 start-page: 951 issue: 10 year: 2018 ident: 10.1016/j.mad.2023.111801_bib39 article-title: Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2017.76.0611 – volume: 143 start-page: 87 issue: 1 year: 2019 ident: 10.1016/j.mad.2023.111801_bib90 article-title: Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas publication-title: J. Neurooncol. doi: 10.1007/s11060-019-03134-x – volume: 140 start-page: 485 issue: 3 year: 2018 ident: 10.1016/j.mad.2023.111801_bib62 article-title: Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review publication-title: J. Neurooncol. doi: 10.1007/s11060-018-03015-9 – volume: 21 start-page: 39 issue: 1 year: 2022 ident: 10.1016/j.mad.2023.111801_bib112 article-title: Glioma targeted therapy: insight into future of molecular approaches publication-title: Mol. Cancer doi: 10.1186/s12943-022-01513-z – volume: 20 start-page: 945 issue: 6 year: 2009 ident: 10.1016/j.mad.2023.111801_bib57 article-title: Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer in the offspring publication-title: Cancer Causes Control doi: 10.1007/s10552-009-9311-5 – volume: 11 issue: 4 year: 2019 ident: 10.1016/j.mad.2023.111801_bib22 article-title: Pathological and molecular features of glioblastoma and its peritumoral tissue publication-title: Cancers – volume: 25 start-page: 283 issue: 3 year: 2014 ident: 10.1016/j.mad.2023.111801_bib38 article-title: Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control study publication-title: Cancer Causes Control doi: 10.1007/s10552-013-0330-x – volume: 73 year: 2021 ident: 10.1016/j.mad.2023.111801_bib3 article-title: Glioblastoma in adolescents and young adults: an age-based comparative study from Jordan over a 17-year period publication-title: Cancer Epidemiol. doi: 10.1016/j.canep.2021.101948 – volume: 22 start-page: 1805 issue: 10 year: 2017 ident: 10.1016/j.mad.2023.111801_bib111 article-title: The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease publication-title: Front. Biosci. doi: 10.2741/4573 – volume: 67 issue: 6 year: 2020 ident: 10.1016/j.mad.2023.111801_bib96 article-title: A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma publication-title: Pedia Blood Cancer doi: 10.1002/pbc.28283 – volume: 21 start-page: 1357 issue: 11 year: 2019 ident: 10.1016/j.mad.2023.111801_bib78 article-title: Risk factors for childhood and adult primary brain tumors publication-title: Neuro Oncol. doi: 10.1093/neuonc/noz123 – volume: 104 start-page: 1251 issue: 16 year: 2012 ident: 10.1016/j.mad.2023.111801_bib91 article-title: Association between prediagnostic IgE levels and risk of glioma publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djs315 – volume: 15 start-page: 145 issue: 1 year: 2020 ident: 10.1016/j.mad.2023.111801_bib103 article-title: Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis publication-title: Radiat. Oncol. doi: 10.1186/s13014-020-01584-6 – volume: 23 start-page: 1985 issue: 10 year: 2014 ident: 10.1016/j.mad.2023.111801_bib101 article-title: Epidemiologic and molecular prognostic review of glioblastoma publication-title: Cancer Epidemiol. Biomark. Prev. doi: 10.1158/1055-9965.EPI-14-0275 |
SSID | ssj0001426 |
Score | 2.5378542 |
SecondaryResourceType | review_article |
Snippet | Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10–15%. For this reason, age is... Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pediatric patients is 10-15%. For this reason, age is... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 111801 |
SubjectTerms | Age Brain Neoplasms - epidemiology Brain Neoplasms - genetics Brain Neoplasms - therapy Female Gender Glioblastoma Glioblastoma - genetics Glioblastoma - therapy High grade glioma Humans Male Mutation Prognosis Risk Factors |
Title | Impact of age and gender on glioblastoma onset, progression, and management |
URI | https://dx.doi.org/10.1016/j.mad.2023.111801 https://www.ncbi.nlm.nih.gov/pubmed/36996926 https://www.proquest.com/docview/2793989107 |
Volume | 211 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-wwEB905YkX0dWn6xcRHh7EPtt8tNnjIsqq6OkJ8i4hSbOy4rai68GLf7uTNF0Q1IPHhiQNM8lvJpkvgD8IhtKWcpRwU9iE8zJLtOAuEQUzPNU0186_Q15d58MbfnErbufgpI2F8W6VEfsbTA9oHVuOIzWPH8djH-PL8XB4S2Own-EVaIGyfi46sDA4vxxezwA546Hqmu-f-AGtcTO4eU20zxdKmccOGUvDfCKevlI_gxg6W4HlqD-SQbPEVZhzVRfWBhXenSev5IAEj87wVN6FxatoOO_Cr_91aFyDy_MQF0nqEUEoIboqyV0oJ0fqitw9jGuD-jROpon3s54ekeDB1WTvOArdJzOPmXW4OTv9dzJMYkWFxDLBpj5mXEsU2cYJW3CUj6k2ueYCT7LVUjpKC1eyvjVCapvRzDJmjS2YExoZh2jwGzpVXblNIKzMXZmntBQ4oxSpcSPhrMcD1PCc4T1IW0IqG9ON-6oXD6r1K7tXSHvlaa8a2vfgcDbkscm18V1n3nJHfdgwCmXBd8P2W04qPEjeOqIrV788K4pI1ZeoPRU92GhYPFsFy_Fa2Kf51s9-ug1L_qtx-NmBzvTpxe2iLjM1ezD_9y3bizv2HVa572g |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTwMhEJ4YjY-L0fqqT0yMB-PqdoFdejSNpmrbU02MFwIsbWrsrtF68OJvd2B3a0zUg1cWWDLANwPzDQNwhGAoTCoGAdOJCRhLG4HizAY8oZqFKoqVdfeQ3V7cvmM39_x-BlpVLIyjVZbYX2C6R-uy5LyU5vnzaORifBluDudp9P4zPALNMU4Tx-s7-_jieTSYz7nmageueuXa9CSvsXKvhUbUIYcoE8P8oJx-Mz69ErpageXSeiQXxQBXYcZmNVi7yPDkPH4nx8TzOf1FeQ0WuqXbvAbzD7kvXIPbax8VSfIBQSAhKkvJ0CeTI3lGhk-jXKM1jZ0p4ljWk1Pi-VvF2x2nvvp4ypdZh7ury36rHZT5FAJDOZ24iHElUGFry03CUDuGSseKcdzHRglhoyixKW0azYUyjahhKDXaJNRyhdOGWLABs1me2S0gNI1tGodRyrFHwUNtB9wahwZo31nN6hBWgpSmfGzc5bx4khWr7FGi7KWTvSxkX4eTaZPn4qWNvyqzanbkt-UiURP81eywmkmJ28j5RlRm87dXGSFONQXaTkkdNospno6CxngobEbx9v9-egCL7X63IzvXvdsdWHJfCurPLsxOXt7sHlo1E73vV-0nVhzwMw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+age+and+gender+on+glioblastoma+onset%2C+progression%2C+and+management&rft.jtitle=Mechanisms+of+ageing+and+development&rft.au=Colopi%2C+Ambra&rft.au=Fuda%2C+Serena&rft.au=Santi%2C+Samuele&rft.au=Onorato%2C+Angelo&rft.date=2023-04-01&rft.pub=Elsevier+B.V&rft.issn=0047-6374&rft.eissn=1872-6216&rft.volume=211&rft_id=info:doi/10.1016%2Fj.mad.2023.111801&rft.externalDocID=S0047637423000271 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0047-6374&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0047-6374&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0047-6374&client=summon |